← Back to Clinical Trials
Recruiting NCT06921902

Glycemic Metrics and Patterns in People With and Without Prediabetes

Trial Parameters

Condition Pre Diabetes
Sponsor Abbott Diabetes Care
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-02-28
Completion 2026-07
Interventions
FreeStyle Libre 3

Brief Summary

The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.

Eligibility Criteria

Inclusion Criteria: * Subject must be at least 18 years of age. * Subject must be willing and able to provide written signed and dated informed consent. Exclusion Criteria: * Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes. * Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment. * Subject is known to be pregnant at the time of enrollment. * Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin. * Subject is currently on any form of treatment indicated for the treatment of diabetes. * Subject is currently on any form of medication indicated for weight loss.

Related Trials